Is Lexaria Bioscience Corp (LEXXW) undervalued? · rev $705.9K
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
This page asks whether Lexaria Bioscience Corp (LEXXW) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
LEXXW currently screens at market cap $33.8M. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new LEXXW 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare LEXXW to the stock page model before you treat a low multiple as a gift.
Not investment advice.